View Post

New research points to potential for single breast cancer radiotherapy shot

In Clinical Studies News by Barbara Jacoby

By: Jack Power, Mark Hilliard From: irishtimes.com New research which suggests a single shot of radiotherapy may be as effective as current treatment for certain types of breast cancers, has been described as promising by the Irish Cancer Society. The University College London (UCL) study, published on Friday, suggests a new treatment may avoid the need for a long course …

View Post

When Does Medicare Cover Mammograms?

In In The News by Barbara Jacoby

From: healthline.com Yearly mammograms are an important screening tool in the early detection of breast cancer. If you have Medicare Part B or a Medicare Advantage plan, both screening and diagnostic mammograms are covered under your plan. However, there may be different coverage levels and out-of-pocket costs depending on your plan and medical situation. In this article, we’ll explore when …

View Post

BARD1 Life Sciences (ASX:BD1) receives positive results from breast cancer study

In Clinical Studies News by Barbara Jacoby

By: Julia Seymour From: themarketherald.com BARD1 Life Sciences (BD1) has received results from a preliminary study demonstrating the feasibility of using SubB2M in an immunohistochemistry (IHC) application for breast cancer tissue The study compared cancer tissue from an invasive ductual breast cancer tumour biopsy to a non-cancer breast tissue biopsy The study also demonstrated that the SubB2M IHC test could …

View Post

GC Aesthetics® Launches Next Generation Of Breast Implants

In In The News by Barbara Jacoby

Source: GC Aesthetics, Inc. From: prnewswire.com GC Aesthetics, Inc. (GCA), a privately-held medical technology company providing aesthetic solutions for global healthcare markets, is pleased to announce the launch of its next generation of breast implants, PERLE™. PERLE™ is a highly innovative line of smooth breast implants that features a proprietary surface technology (BioQ™), GCA’s industry-leading gel technology (Emunomic™ Breast Tissue …

View Post

Most Oncology Trials Fail to Report Timely Results

In Clinical Studies News by Barbara Jacoby

By: Mike Bassett From: medpagetoday.com Situation steadily improving since passage of FDAAA, however While fewer than 40% of completed oncology trials in 2017 reported their results in a timely fashion, that percentage was eight times higher compared with a decade ago, researchers reported. Among more than 12,000 clinical trials registered in ClinicalTrials.gov, the percentage reporting results within 24 months of …

View Post

Breast Cancer and Shingles

In In The News by Barbara Jacoby

Source: FeatureFriday From: survivingbreastcancer.org Is there a relationship? Studies indicate that there may be a correlation. Talk about one’s body multi-tasking in a most adversarial way! During a recent survivingbreastcancer.org virtual meet up, a number of the community stated they had developed shingles. The conversation stimulated much in the way of follow up. What we do know: Shingles is caused …

View Post

New biosensor developed to aid early diagnosis of breast cancer

In Clinical Studies News by Barbara Jacoby

By: Universitat Politècnica de València From: medicalxpress.com A team of Spanish researchers have developed, at the laboratory level, a prototype of a new biosensor to help detect breast cancer in its earliest stages. One of the team coordinators has been Ramón Martínez Máñez, a professor at the Universitat Politècnica de València (UPV) and the scientific director of the Networking Biomedical …

View Post

Radical Mastectomy: What You Need to Know

In In The News by Barbara Jacoby

From: healthline.com A mastectomy is surgery to remove a breast. There are several types of mastectomy, including total, modified radical, and radical. A radical mastectomy is the most extensive type. During the procedure, the surgeon removes the entire breast along with the underarm (axillary) lymph nodes and chest wall muscles. In this article, we’ll take a closer look at radical …

View Post

Tumor marker may help overcome endocrine treatment-resistant breast cancer

In Clinical Studies News by Barbara Jacoby

By: Sanford Burnham Prebys Medical Discovery Institute From: medicalxpress.com A study led by scientists at Sanford Burnham Prebys Medical Discovery Institute has identified a tumor marker that may be used to predict which breast cancer patients will experience resistance to endocrine therapy. The research offers a new approach to selecting patients for therapy that targets HER2, a protein that promotes …